A group of zeaxanthin suppliers have united to form the Zeaxanthin Trade Association to increase global awareness of the eye health nutrient and adopt quality standards.
A combination of antioxidant pigments and vitamins may slow down sight loss in elderly people, according to researchers from Queen’s University, Belfast.
Iowa-based supplier, Kemin Health, has been reissued patents first issued in 1995 that will “solidify its position” as a leading supplier of the eye health ingredient, lutein.
Zeaxanthin supplier, Chrysantis, has added a secondary analysis method to its marigold-sourced zeaxanthin manufacturing processes, driven by its customers’ needs to meet GMPs.
Kemin Health has launched an initiative with the American Optometric Association (AOA) to deliver eye health information to optometrists and their patients as it expands its lutein-based, eye health education program.
Chrysantis said it is developing its eye-health ingredient zeaxanthin for use in food and beverages as the company announced it is boosting its sales force to meet growing demand in the supplement sector.
The use of rising eye health phytonutrient, zeaxanthin, in food
supplements in doses of up to 20mg has been rejected by the
European Food Safety Authority (EFSA).
Rising eye-health ingredient zeaxanthin has been launched in a
tablet-friendly form by one of the world's big three players -
Illinois-based Chrysantis.
Ingredient group ZMC has been granted a lutein and zeaxanthin
patent, which the company hopes will help position it as a leading
global supplier for the two dietary supplement ingredients.
Kemin has announced a deal with DSM to strengthen an agreement to
supply lutein aimed at eye health around the world, which will see
DSM step up supply of FloraGLO.
Chrysantis announced its branded zeaxanthin has achieved Generally
Regarded As Safe (GRAS) status, opening up the potential for the
ingredient to be used in a new category of functional food and
beverages.
Vitiva is introducing a lutein ester ingredient extracted from
marigold flowers that is being aimed at enabling higher
dosages in dietary supplements in the US and Europe.
A new human study has shown that Cognis' Xangold lutein and
zeaxanthin ingredient is effective at boosting the eye health of
those with early-stage age-related macular degeneration (AMD).
A stable intake of the carotenoids, lutein and zeaxanthin, could
reduce the risk of age related macular degeneration by 43 per cent
in women under 75, says a new cohort study.
ZeaVision is planning to support the latest licensee of its
zeaxanthin patent, fulfilling some of its requirements for its
EyePromise supplement line from Kalsec.
A healthy diet containing plenty of antioxidants and fish can
reduce the risk of age-related macular degeneration (AMD), says a
new study from Harvard Medical School.
An article that casts doubts on the effectiveness of eye health
supplements has led industry members and scientists to leap to the
defence of lutein and zeaxathin, which they are confident has been
shown to improve the visual function...
UK consumer watchdog Which? has cast doubts over the effectiveness
of eye health supplements in an article that could affect
confidence in products and have a detrimental affect on the
industry.
Kalsec has launched its paprika-derived zeaxanthin ZeaGold onto the
eye health ingredients market, following a patent licensing
agreement with ZeaVision.
Cognis has been denied permission to make a qualified health claim
for the consumption of its Xangold brand lutein esters and reduced
risk of age-related macular degeneration and cataracts.
Supplement makers have been tapping into consumer's eye health
anxieties for the last four years and although product launches
seem to have peaked in 2003, there are no signs of a serious
slow-down, reports Jess Halliday.
An extract of resveratrol-rich walnuts could offer supplement
makers a new ingredient for tackling the onset of age-related
macular degeneration, writes Dominique Patton.
Chrysantis is ready to start selling EZ Eyes to dietary supplement
makers following the FDA's acceptance of the marigold-derived
natural zeaxanthin as a new dietary ingredient (NDI), reports
Jess Halliday.
Blue California is launching four non-irradiated botanical extracts
at Vitafoods in Geneva this week, the first in a new line which
aims to meet manufacturers' demands for ingredients that meet the
strictest regulatory controls...
Ball Horticultural-subsidiary Chrysantis has signed a licensing
agreement with ZeaVision for the marketing and selling of
zeaxanthin, a deal which gives it limited, non-exclusive license
store of the supplement maker's patents...
Cognis Nutrition & Health is introducing a vegetarian version
of its marigold-derived Xangold 10% microencapsulated lutein ester
beadlets for tablet and dry food formulators seeking to meet the
needs of a burgeoning vegetarian...
New company Chrysantis' plan to bring to market proprietary
marigold extracts with a high natural zeaxanthin content could give
eye health product formulators a new tool to help combat
age-related macular degeneration (ARMD),...
The Federal Trade Commission (FTC) has settled with the seller of a
supplement containing lutein over claims that the product could
restore vision already lost form age related macular degeneration
(AMD) and remove specks, known as...
California-based BI Nutraceuticals has joined with Mexican raw
materials manufacturer Pigmentos Vegetales del Centro (PIVEG) to
become the North American distributor for the company's
ingredients.
A jury has voted to uphold Kemin Industries' patents for the
chemical composition and production process of lutein, in a trial
in Des Moines, Iowa, against Pigmentos Vegetales del Centro.
A jury in the US has voted to uphold Kemin Industries' patents for
the chemical composition and production process of lutein, in a
trial in Des Moines, Iowa, against Pigmentos Vegetales del Centro.
Lutein supplements, shown previously to fortify the macular layer
in the eye and thought to protect against age-related blindness,
also appear to increase macular pigment in people at earlier stages
of age-related macular degeneration...
Pressure from B2B customers has encouraged Kemin Foods to attain
the ISO 9001:2000 certification for the design and manufacture of
its purified lutein as a food and dietary supplement.
Eating fruit may help protect against the development of
age-related maculopathy (ARM), an eye disease that can cause
blindness, according to US scientists.
A new study supports growing evidence that eating fruit - thanks to
the protective antioxidants they contain - can help men and women
fight against the onset of age-related maculopathy (ARM), a
degenerative eye disease that can cause...
Kemin foods, the US manufacturer and marketer of nutritional
ingredients for the food and dietary supplement market is to launch
the first vegetarian lutein ingredient onto the market. The firm is
looking to drive this preservative...
A new study has found that most lutein and zeaxanthin supplements
meet their ingredients claims but often vary largely in strength.
Daily doses varied by 90-fold from as little as 0.25 mg to as much
as 22.5 mg per day, reports ConsumerLab.com.
A technology that allows the health ingredient lutein to be
delivered to clear beverages has been given GRAS (Generally
Recognized As Safe) status from the US Food and Drug
Administration.
The leading US eye health supplement, made by Bausch & Lomb,
gained a US patent this week, prompting the company to launch suits
against four of its competitors.
A new study showing a hefty increase in age-related eye disease
among older Americans in the last eight years, demonstrates further
the need for preventive approaches, such as eye health supplements.
Kemin Foods has earned expanded GRAS status for increased amounts
of its lutein in the current GRAS food categories and for use as an
ingredient in new foods such as bottled water, chewing gum and
salad dressings.
US health ingredients manufacturer Kemin Foods has received
approval for use of its FloraGLO brand lutein in dietary
supplements in France, the company announced today.
Survey results released this week by the AMD Alliance, an
international coalition of eye care charities and organisations,
revealed that GPs feel 'left in the dark' when it comes to
recognising and treating Age Related Macular...
A study by researchers in Manchester, England, suggests that
Cognis' Xangold natural lutein ester supplements may promote eye
health in the elderly. If the evidence is confirmed, dietary
supplements and a higher intake of fruits...
A new lutein product, called Xantiol, has been created by the
French company Nutralica and designed to help treat age-related
macular degeneration (AMD).
A new supplement containing zeaxanthin, a nutrient which is thought
to slow or even prevent macular degeneration, has been launched by
the US group ZeaVision. Macular degeneration is a leading cause of
blindness in people over the...
